Buy & Sell Rivian Automotive, Inc. (RIVN) – Rivian Automotive, Inc. Price Today
Aura AI Summary
Key Stats
- $21.96BMarket Cap
- Consumer CyclicalSector
- -27.28%3M Drawdown
- $23.70BEnterprise Value
- -Dividend Yield
- 59 daysTypical Hold Time
Rivian Automotive, Inc. (RIVN) is currently valued at a market capitalization of $21.96B, with an enterprise value of $23.70B. Over the past 52 weeks, Rivian Automotive, Inc. has traded between a low of $11.64 and a high of $22.45, highlighting its annual price range. Over the past three months, Rivian Automotive, Inc. has recorded a drawdown of -27.28%, reflecting recent price volatility. On average, investors hold Rivian Automotive, Inc. for approximately 59 days, indicating typical investor behavior on the platform.
About Rivian Automotive, Inc.
Rivian Automotive, Inc. is an automotive technology company. The Company designs and manufactures vans, trucks, and sports utility vehicles, as well as offers repair and maintenance services. Rivian Automotive serves customers in North America and the United Kingdom.
Most Recent News
Digital Realty launches Malaysia data center operations to boost Southeast Asia's digital and AI infrastructure.
Digital Realty has officially launched its Malaysia operations with a new data center campus in Cyberjaya, aiming to expand its capacity to 32 MW. This development integrates Malaysia into Digital Realty's global network, supporting AI and data-drive...

Amcor offers 7% dividend yield with 28% upside potential amid volume recovery and synergy gains.
Amcor's shares have declined nearly 9% in the first half of the year, pushing its dividend yield close to 7%, making it an attractive investment opportunity. Despite volume declines following its acquisition of Berry, the company expects recovery by ...

Novartis to present key Phase III data on Rhapsido for chronic urticaria and food allergy at EAACI 2026.
Novartis will showcase results from multiple clinical trials of Rhapsido (remibrutinib) at the EAACI Congress 2026, including pivotal Phase III data for chronic inducible urticaria and extension data for chronic spontaneous urticaria. The presentatio...
